| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| AMWLAmerican Well Corporation | 70.09M | 4.76 | -0.34 | -1.81% | -42.8% | -42.43% | 0.03 | |
| TDOCTeladoc Health, Inc. | 1.16B | 6.53 | -1.11 | -1.26% | -8.84% | -16.06% | 24.41% | 1.06 |
| EUDAEUDA Health Holdings Limited | 69.19M | 1.83 | -3.89 | 8.22% | 5.17% |
| Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|
| Sales/Revenue | 8.88M | 4.56M | 3.76M | 3.71M | 4.01M |
| Revenue Growth % | - | -0.49% | -0.17% | -0.02% | 0.08% |
| Cost of Goods Sold | 4.99M | 3.31M | 2.89M | 2.86M | 3.25M |
| COGS % of Revenue | 0.56% | 0.73% | 0.77% | 0.77% | 0.81% |
| Gross Profit | 3.89M | 1.25M | 870K | 842.08K | 762.15K |
| Gross Margin % | 0.44% | 0.27% | 0.23% | 0.23% | 0.19% |
| Gross Profit Growth % | - | -0.68% | -0.3% | -0.03% | -0.09% |
| Operating Expenses | 4.78M | 1.81M | 13.09M | 4.8M | 18.1M |
| OpEx % of Revenue | 0.54% | 0.4% | 3.48% | 1.3% | 4.51% |
| Selling, General & Admin | 4.63M | 1.81M | 6.75M | 4.8M | 3.34M |
| SG&A % of Revenue | 0.52% | 0.4% | 1.79% | 1.3% | 0.83% |
| Research & Development | 158.01K | 129.26K | 17.21K | 0 | 0 |
| R&D % of Revenue | 0.02% | 0.03% | 0% | - | - |
| Other Operating Expenses | 0 | -129.26K | 6.32M | 0 | 14.76M |
| Operating Income | -893.56K | -559.99K | -5.72M | -3.96M | -17.34M |
| Operating Margin % | -0.1% | -0.12% | -1.52% | -1.07% | -4.32% |
| Operating Income Growth % | - | 0.37% | -9.21% | 0.31% | -3.38% |
| EBITDA | -669.44K | -295.89K | -5.46M | -3.85M | -17.16M |
| EBITDA Margin % | -0.08% | -0.06% | -1.45% | -1.04% | -4.28% |
| EBITDA Growth % | - | 0.56% | -17.46% | 0.3% | -3.46% |
| D&A (Non-Cash Add-back) | 224.12K | 264.1K | 256.26K | 111.2K | 173.22K |
| EBIT | -893.56K | 1.08M | -24.81M | -8.41M | -17.6M |
| Net Interest Income | -65.82K | 1.79M | -93.78K | -23.23K | -44.89K |
| Interest Income | 0 | 1.92M | 0 | 0 | 0 |
| Interest Expense | 65.82K | 127.13K | 93.78K | 23.23K | 44.89K |
| Other Income/Expense | 1.14M | 2.23M | -19.21M | -4.47M | -307.38K |
| Pretax Income | 246.45K | 1.67M | -24.93M | -8.43M | -17.64M |
| Pretax Margin % | 0.03% | 0.37% | -6.62% | -2.28% | -4.4% |
| Income Tax | 47.48K | 46.49K | -20.79K | 0 | -4.38K |
| Effective Tax Rate % | 0.71% | 0.52% | 1% | 1.19% | 0.87% |
| Net Income | 175.57K | 864.83K | -24.88M | -10.04M | -15.36M |
| Net Margin % | 0.02% | 0.19% | -6.61% | -2.71% | -3.83% |
| Net Income Growth % | - | 3.93% | -29.77% | 0.6% | -0.53% |
| Net Income (Continuing) | 198.97K | 1.62M | -25.01M | -8.43M | -17.64M |
| Discontinued Operations | 0 | -722.44K | 58.66K | -1.6M | 2.25M |
| Minority Interest | 43.23K | 78.82K | 13.48K | 16.61K | -19.01K |
| EPS (Diluted) | 0.02 | 0.09 | -2.07 | -0.44 | -0.47 |
| EPS Growth % | - | 2.95% | -23.14% | 0.79% | -0.07% |
| EPS (Basic) | 0.02 | 0.09 | -2.07 | -0.37 | -0.47 |
| Diluted Shares Outstanding | 7.42M | 9.25M | 12.03M | 22.9M | 32.46M |
| Basic Shares Outstanding | 7.42M | 9.25M | 12.03M | 27.25M | 32.46M |
| Dividend Payout Ratio | - | - | - | - | - |
| Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|
| Total Current Assets | 4.27M | 4.35M | 25.03M | 723.44K | 762.88K |
| Cash & Short-Term Investments | 250.77K | 190K | 57.54K | 189K | 237.6K |
| Cash Only | 250.77K | 190K | 57.54K | 189K | 237.6K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.61M | 4.09M | 192.85K | 239.19K | 170.27K |
| Days Sales Outstanding | 66.41 | 327.35 | 18.7 | 23.55 | 15.49 |
| Inventory | 0 | 0 | 648.16K | 0 | 128.98K |
| Days Inventory Outstanding | - | - | 81.74 | - | 14.49 |
| Other Current Assets | 2.35M | 2.8K | 24.12M | 295.25K | 226.03K |
| Total Non-Current Assets | 1.61M | 3.65M | 602.56K | 587.07K | 967.34K |
| Property, Plant & Equipment | 137.41K | 161.16K | 124.5K | 206.99K | 316.26K |
| Fixed Asset Turnover | 64.59x | 28.29x | 30.24x | 17.91x | 12.68x |
| Goodwill | 1.01M | 992.69K | 0 | 0 | 0 |
| Intangible Assets | 461.29K | 289.96K | 0 | 0 | 337.3K |
| Long-Term Investments | 0 | 2.2M | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 2.2M | 478.06K | 380.07K | 281.38K |
| Total Assets | 5.88M | 8M | 25.63M | 1.31M | 1.73M |
| Asset Turnover | 1.51x | 0.57x | 0.15x | 2.83x | 2.32x |
| Asset Growth % | - | 0.36% | 2.2% | -0.95% | 0.32% |
| Total Current Liabilities | 6.09M | 7.32M | 29.12M | 8.72M | 4.14M |
| Accounts Payable | 1.48M | 2.82M | 1.46M | 1.29K | 25.89K |
| Days Payables Outstanding | 108.13 | 311.01 | 184.3 | 0.16 | 2.91 |
| Short-Term Debt | 657.17K | 353.73K | 3.57M | 3.17M | 1.04M |
| Deferred Revenue (Current) | 0 | 0 | -1000K | 0 | 477.92K |
| Other Current Liabilities | 3.46M | 3.82M | 25.14M | 4.6M | -624 |
| Current Ratio | 0.70x | 0.59x | 0.86x | 0.08x | 0.18x |
| Quick Ratio | 0.70x | 0.59x | 0.84x | 0.08x | 0.15x |
| Cash Conversion Cycle | - | - | -83.87 | - | 27.08 |
| Total Non-Current Liabilities | 104.3K | 82.95K | 15.02K | 75.11K | 160.91K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 25.88K | 33.65K | 15.02K | 75.11K | 51.8K |
| Deferred Tax Liabilities | 0 | 49.29K | 0 | 0 | 76.7K |
| Other Non-Current Liabilities | 78.42K | 0 | 0 | 0 | 32.4K |
| Total Liabilities | 6.2M | 7.4M | 29.14M | 8.79M | 4.3M |
| Total Debt | 709.97K | 462.31K | 3.63M | 3.37M | 1.27M |
| Net Debt | 459.2K | 272.31K | 3.57M | 3.19M | 1.03M |
| Debt / Equity | - | 0.77x | - | - | - |
| Debt / EBITDA | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - |
| Interest Coverage | -13.58x | -4.41x | -60.98x | -170.55x | -386.17x |
| Total Equity | -317.36K | 600.05K | -3.51M | -7.48M | -2.57M |
| Equity Growth % | - | 2.89% | -6.84% | -1.13% | 0.66% |
| Book Value per Share | -0.04 | 0.06 | -0.29 | -0.33 | -0.08 |
| Total Shareholders' Equity | -360.59K | 521.23K | -3.52M | -7.5M | -2.55M |
| Common Stock | 334.86K | 334.86K | 21.31M | 27.43M | 47.81M |
| Retained Earnings | -684.5K | 180.33K | -24.7M | -34.74M | -50.1M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -10.96K | 6.04K | -125.69K | -185.47K | -260K |
| Minority Interest | 43.23K | 78.82K | 13.48K | 16.61K | -19.01K |
| Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|
| Cash from Operations | -411.88K | 443.92K | -1.53M | -2.92M | -2.03M |
| Operating CF Margin % | -0.05% | 0.1% | -0.41% | -0.79% | -0.51% |
| Operating CF Growth % | - | 2.08% | -4.44% | -0.91% | 0.3% |
| Net Income | 198.97K | 900.4K | -24.95M | -8.44M | -17.6M |
| Depreciation & Amortization | 285.38K | 264.1K | 172.02K | 119.35K | 173.22K |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | -32.27K | -27.68K | -48.23K | 0 | -4.38K |
| Other Non-Cash Items | -85.21K | -1.87M | 22.18M | 4.87M | 15.21M |
| Working Capital Changes | -778.75K | 1.18M | 1.12M | 531.2K | 194.93K |
| Change in Receivables | 735.82K | -263.95K | -174.82K | -32.97K | 82.35K |
| Change in Inventory | 0 | 0 | 3.69M | 0 | -126.27K |
| Change in Payables | -791.25K | 1.38M | -1.13M | 1.27K | 15.99K |
| Cash from Investing | 179.34K | -356.18K | -268.21K | 0 | -147.77K |
| Capital Expenditures | -76.06K | -1.96K | -18.14K | -5 | -116.03K |
| CapEx % of Revenue | 0.01% | 0% | 0% | 0% | 0.03% |
| Acquisitions | - | - | - | - | - |
| Investments | - | - | - | - | - |
| Other Investing | 0 | 0 | -246.66K | 5 | -48.03K |
| Cash from Financing | 212.51K | -168.37K | 2.49M | 2.35M | 2.32M |
| Debt Issued (Net) | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - |
| Other Financing | 182.52K | -161.69K | -9.47K | 121.88K | 115.14K |
| Net Change in Cash | - | - | - | - | - |
| Free Cash Flow | -487.94K | 441.96K | -1.54M | -2.92M | -2.15M |
| FCF Margin % | -0.05% | 0.1% | -0.41% | -0.79% | -0.54% |
| FCF Growth % | - | 1.91% | -4.5% | -0.89% | 0.26% |
| FCF per Share | -0.07 | 0.05 | -0.13 | -0.13 | -0.07 |
| FCF Conversion (FCF/Net Income) | -2.35x | 0.51x | 0.06x | 0.29x | 0.13x |
| Interest Paid | 66.19K | 110.83K | 19.59K | 17.52K | 55.38K |
| Taxes Paid | 12.58K | 30.18K | 156.34K | 42.9K | 11.63K |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Return on Equity (ROE) | - | 611.85% | - | - | - |
| Return on Invested Capital (ROIC) | -472.47% | -82.82% | -913.9% | - | - |
| Gross Margin | 43.83% | 27.42% | 23.11% | 22.72% | 19% |
| Net Margin | 1.98% | 18.97% | -661.06% | -270.86% | -382.87% |
| Debt / Equity | - | 0.77x | - | - | - |
| Interest Coverage | -13.58x | -4.41x | -60.98x | -170.55x | -386.17x |
| FCF Conversion | -2.35x | 0.51x | 0.06x | 0.29x | 0.13x |
| Revenue Growth | - | -48.64% | -17.42% | -1.54% | 8.22% |
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Property Management Services | 3.76M | 3.71M | 3.92M |
| Property Management Services Growth | - | -1.54% | 5.81% |
| Product Sales | - | - | 89.02K |
| Product Sales Growth | - | - | - |
| Medical Service | 6.08M | - | - |
| Medical Service Growth | - | - | - |
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Property Management Services | - | - | 3.92M |
| Property Management Services Growth | - | - | - |
| Product Sales | - | - | 89.02K |
| Product Sales Growth | - | - | - |
EUDA Health Holdings Limited (EUDA) reported $5.2M in revenue for fiscal year 2024. This represents a 42% decrease from $8.9M in 2020.
EUDA Health Holdings Limited (EUDA) grew revenue by 8.2% over the past year. This is steady growth.
Yes, EUDA Health Holdings Limited (EUDA) is profitable, generating $0.3M in net income for fiscal year 2024 (-382.9% net margin).
EUDA Health Holdings Limited (EUDA) had negative free cash flow of $2.1M in fiscal year 2024, likely due to heavy capital investments.